Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies

Abroad (travel likely)RecruitingPHASE2

Conditions

Cytomegalovirus (CMV)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Seoul National University Hospital, Seoul, South Korea
Contact: Study coordinator (Ja Min Byun, MD, PhD) · jaminbyun@snu.ac.kr · 82-2-2072-7215

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

Cytomegalovirus (CMV)

Abroad (travel likely)RecruitingPHASE3

Hefei, China · Chongqing, China

A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection

Cytomegalovirus (CMV)

Abroad (travel likely)Recruiting

Tokyo, Japan

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Cytomegalovirus (CMV)

IsraelRecruitingPHASE3

Wilmington, United States · St. Petersburg, United States

A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Cytomegalovirus (CMV)

Abroad (travel likely)Recruiting

City of Buenos Aires, Argentina